InMed Pharmaceuticals Inc (INM) Live Share Price, Invest From India

InMed Pharmaceuticals Inc Stock Performance

as on June 17, 2026 at 6:59 am IST

Day's Low
Day's High
$1.47
Day's Price Range
$1.50
$1.49
1.34%
Downside
0.67%
Upside
52 Week's Low
52 Week's High
$0.58
52-Week Price Range
$5.50
$1.49
61.41%
Downside
269.13%
Upside

InMed Pharmaceuticals Inc share price movements today

Previous Close: $1.51
Open: $1.48
Volume: 906.0K
Day's Low - High: $1.47 - $1.50
52 Week Low - High: $0.58 - $5.50

InMed Pharmaceuticals Inc Historical Returns

1 Month Return: + 135.9 %
3 Month Return: + 75.26 %
1 Year Return: -36.29 %
3 Year Return: -93.86 %
5 Year Return: -99.89 %

InMed Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check InMed Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.0M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-7.8M

Revenue (TTM)

4.9M

Profit Margin

-172.17%

Return On Equity TTM

-112.65%

InMed Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of InMed Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
InMed Pharmaceuticals Inc	SELL	$5.0M	-99.89%	NA	-172.17%	NA
United Therapeutics Corporation	BUY	$23.3B	199.59%	20.34	40.62%	NA
Viatris Inc	HOLD	$19.2B	7.23%	NA	-2.04%	2.94%
Haleon plc	BUY	$40.0B	NA	18.14	15.11%	2.13%
Zoetis Inc	BUY	$33.5B	-56.57%	13.11	28.04%	2.55%

See all

Stock Returns calculator for InMed Pharmaceuticals Inc Stock including INR - Dollar returns

The InMed Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

InMed Pharmaceuticals Inc investment value today

Current value as on today

₹69,244

Returns

-₹30,756

(-30.76%)

Returns from InMed Pharmaceuticals Inc Stock

-₹37,131 (-37.13%)

Dollar Impact

₹6,375 (+6.37%)

Analyst Recommendation on InMed Pharmaceuticals Inc Stock

Based on 8 analysts

SELL

0.00%

Buy

37.50%

Hold

62.50%

Sell

Based on 8 analysts, 62.5% of analysts recommend a 'SELL' rating for InMed Pharmaceuticals Inc. Average target price of $20

InMed Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on InMed Pharmaceuticals Inc.

What analysts predicted

92.55%UPSIDE

Target Price

$20

Current Price

$1.49

Analyzed by

8 Analysts

Target

$20.00

InMed Pharmaceuticals Inc target price $20, a slight upside of 92.55% compared to current price of $1.49. According to 8 analysts rating.

Indian Investors' Interest in InMed Pharmaceuticals Inc Stock

Investment in InMed Pharmaceuticals Inc Shares on INDmoney has grown by 10600.00% in the last 30 days, indicating increased investment activity.

Time period: May 18, 2026 to June 17, 2026

Change:10600.00% versus previous 30 day period

Search interest for InMed Pharmaceuticals Inc Stock has increased by 1058% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 18, 2026 to June 17, 2026

Change:1058% versus previous 30 day period

InMed Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	0	0	0	1	1	1	1	1	659
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-1	-1	-2	-1	-2	-2	-2	-1	-2	-2
EBITDA	-1	-1	-1	-1	-2	-1	-2	-1	-2	-2
Interest Expense	-	-	-	-	0	-	0	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	-1	-1	-2	-2	-2	-1	-2	-2
Income Tax Expense	0	0	0	-	-	-	-	-	-	-
Net Income	-1	-1	-1	-1	-2	-2	-2	-1	-2	-2
Net Profit Margin	-119.19%	-146.93%	-151.02%	-132.68%	-231.63%	-168.12%	-137.07%	-154.17%	-247.29%	-0.45%

InMed Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	-	-	-	-	-	0	3	3	4
Gross Profit	0	0	0	0	0	0	1	0	1
Operating Income	-4	-8	-13	-9	-12	-13	-8	-8	-7
EBITDA	-3	-8	-10	-8	-12	-18	-7	-7	-7
Interest Expense	0	0	0	0	0	0	-	-	0
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-8	-13	-8	-12	-18	-7	-7	-8
Income Tax Expense	0	0	0	0	0	4	0	0	-
Net Income	-2	-6	-7	-6	-10	-14	-5	-5	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-1707.32%	-192.18%	-166.94%	-165.14%

InMed Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-1	-1	-1	-2	-2	-1	-2	-3,753	-2
Operating Cash Flow	-1	-1	-1	-2	-1	-1	-2	-3	-1
Investing Cash Flow	0	0	-	-	-	-	-	-	-
Financing Cash Flow	0	0	0	0	2	8	0	0	0
Change in Cash	-1	-1	0	-2	1	6	-2	-3	-1

InMed Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-3	-6	-10	-8	-10	-18	-7	-7	-8
Operating Cash Flow	-2	-3	-8	-7	-9	-15	-7	-6	-7
Investing Cash Flow	0	-1	-2	3	0	0	0	0	-
Financing Cash Flow	7	19	0	0	10	15	10	4	12
Change in Cash	5	13	-11	-4	1	-1	2	-2	4

Global Institutional Holdings in InMed Pharmaceuticals Inc

Funds	Holdings
UBS Group AG	0.24%
Federation des caisses Desjardins du Quebec	0%
DRW Securities, LLC	0%
Tower Research Capital LLC	0%
Jane Street Group LLC	0%

See all

Insights on InMed Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 68.54% to 69.47% in Mar 2026 quarter
POSITIVE IMPACT
Price Rise
In the last 1 month, INM stock has moved up by 135.9%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 1.12M → 659.84M (in $), with an average increase of 50.2% per quarter
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, INM has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 1 year, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 90.7% return, outperforming this stock by 127.0%
NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 26.20% to 26.13% in Mar 2026 quarter
NEGATIVE IMPACT
Price Dip
In the last 6 months, INM stock has moved down by -34.4%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -1.72M → -2.96M (in $), with an average decrease of 33.9% per quarter
NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 5.26% to 4.40% in Mar 2026 quarter

About InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with unmet medical needs. The company's lead product consists of INM-755, a cannabinol topical skin cream that has completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-089, a small molecule compound that acts as a selective dual CB1/CB2 agonist; and INM-900 for neurodegenerative diseases, as well as INM-901, a small molecule for treatment of Alzheimer's disease. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.

Organisation	InMed Pharmaceuticals Inc
Headquarters	885 West Georgia Street, Vancouver, BC, Canada, V6C 3E8
Industry	Drug Manufacturers - Specialty & Generic
CEO	Mr. Eric A. Adams B.S. Chem., M.I.B.
E-voting on shares	Click here to vote

Key Management of InMed Pharmaceuticals Inc

Name	Title
Ms. N. Netta Jagpal	CFO & Corporate Secretary
Mr. Michael Woudenberg P.Eng.	Chief Operating Officer
Dr. Eric Chih-Hsien Hsu Ph.D.	Senior Vice President of Preclinical Research & Development
Dr. Sazzad Hossain M.Sc., Ph.D.	Co-Founder
Mr. Colin Clancy	VP of Investor Relations & Corporate Communications
Mr. Jerry P. Griffin	Vice President of Sales & Marketing
Dr. Shane A. Johnson Ph.D.	Senior VP & GM of BayMedica
Mr. Eric A. Adams B.S. Chem., M.I.B.	President, CEO & Director

FAQs

What is InMed Pharmaceuticals Inc share price today?

InMed Pharmaceuticals Inc share price today is $1.49 as on June 17, 2026 at 1:29 am IST at the close of the market. InMed Pharmaceuticals Inc share today touched a day high of $1.5 and a low of $1.47.

What is the 52 week high and 52 week low for InMed Pharmaceuticals Inc share?

InMed Pharmaceuticals Inc share touched a 52 week high of $5.5 on June 24, 2025 and a 52 week low of $0.58 on March 31, 2026. InMed Pharmaceuticals Inc stock price today i.e. June 17, 2026 at 1:29 am IST is closed at $1.49,which is 72.91% down from its 52 week high and 159.13% up from its 52 week low.

What is InMed Pharmaceuticals Inc's market capitalisation today?

InMed Pharmaceuticals Inc market capitalisation is $0.00T as on June 17, 2026 at 1:29 am IST.

How to invest in InMed Pharmaceuticals Inc Stock (INM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for InMed Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in InMed Pharmaceuticals Inc Shares that will get you 1.0067 shares as per InMed Pharmaceuticals Inc share price of $1.49 per share as on June 17, 2026 at 1:29 am IST.

What is the minimum amount required to buy InMed Pharmaceuticals Inc Stock (INM) from India?

Indian investors can start investing in InMed Pharmaceuticals Inc (INM) shares with as little as ₹94.55 or $1 (as of June 17, 2026 at 1:58 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹945.50 in InMed Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on June 17, 2026 at 1:58 am IST). Based on InMed Pharmaceuticals Inc share’s latest price of $1.49 as on June 17, 2026 at 1:29 am IST, you will get 6.7114 shares of InMed Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that InMed Pharmaceuticals Inc has given to Indian investors in the last 5 years?

InMed Pharmaceuticals Inc stock has given -99.89% share price returns and 29.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?